A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DOX

Search Conditions:
Search Keyword : Dox
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: DOX
Appearance Frequency: 8757 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
doxorubicin
(8281 times)
Pharmacology
(1496 times)
MDR (481 times)
P-gp (347 times)
ROS (345 times)
1979 Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells.
doxorubicin hydrochloride
(372 times)
Chemistry
(88 times)
NPs (25 times)
MSNs (19 times)
NIR (19 times)
1986 Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.
doxazosin
(28 times)
Vascular Diseases
(6 times)
ALF (4 times)
BP (4 times)
BPH (3 times)
1987 A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension.
doxepin
(25 times)
Pharmacology
(8 times)
AMI (8 times)
IMI (5 times)
DDOX (4 times)
1978 Doxepin kinetics.
copolymer-doxorubicin
(19 times)
Pharmacology
(7 times)
HPMA (10 times)
MW (2 times)
Ab (1 time)
1999 Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
dioxygenase
(12 times)
Biochemistry
(7 times)
AOS (5 times)
LDS (3 times)
bph (2 times)
1994 Construction of hybrid biphenyl (bph) and toluene (tod) genes for functional analysis of aromatic ring dioxygenases.
doxycycline hyclate
(11 times)
Chemistry
(2 times)
beta-CD (1 time)
DAAP (1 time)
GCF (1 time)
2007 Intra-articular administration of doxycycline in calves.
docetaxel
(9 times)
Biochemistry
(2 times)
3'-UTRs (1 time)
AICP (1 time)
BCa (1 time)
2009 Weekly administration of docetaxel and epirubicin as first-line treatment for hormone-refractory prostate carcinoma.